Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003146012 | SCV003834269 | likely pathogenic | Polyglandular autoimmune syndrome, type 1 | 2022-07-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003146012 | SCV004282073 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2023-06-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 2440711). This variant has not been reported in the literature in individuals affected with AIRE-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu67*) in the AIRE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AIRE are known to be pathogenic (PMID: 11524731, 26141571). |
Center for Genomic Medicine, |
RCV003146012 | SCV004809382 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2024-04-04 | criteria provided, single submitter | clinical testing |